InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Discover the full record of transactions filed by Arbuckle Stuart A, Chief Executive Officer. Insider active across 2 companies, notably VERTEX PHARMACEUTICALS INC / MA. Aggregated, 11 reports have been recorded. Total volume traded: €83k. The latest transaction was disclosed on 16 May 2022 — Cession. Regulator: SEC (Form 4). The full history is openly available.
Declarations11 total
€2,59411 shares@ €235.85690.0000% mcap0.1% of flow
Common Stock
SEC:0000899243-22-018610:0·
€76,865306 shares@ €251.19280.0001% mcap2.5% of flow
Common Stock
SEC:0000899243-22-016653:0·
€1m7,246 shares@ €201.54450.0013% mcap48.4% of flow
Common Stock
SEC:0000899243-22-008111:0·
€843,3534,126 shares@ €204.39950.0008% mcap27.9% of flow
Common Stock
SEC:0000899243-22-007205:0·
€632,7793,040 shares@ €208.15090.0006% mcap21.0% of flow
Common Stock
SEC:0001209191-22-009233:0·
09,800 shares0
Common Stock
SEC:0001209191-22-006767·
09,800 shares0
Common Stock
SEC:0001209191-22-006767:0·
€3272 shares@ €163.4293100.0% of flow
Common Stock
SEC:0001209191-21-064738·
€3272 shares@ €163.42930.0000% mcap0.0% of flow
Common Stock
SEC:0001209191-21-064738:0·
€1,2407 shares@ €177.12610.0000% mcap100.0% of flow
Common Stock
SEC:0001209191-21-033984·
€1,2407 shares@ €177.12610.0000% mcap0.0% of flow
Common Stock
SEC:0001209191-21-033984:0·
11 of 11 declarations
About Arbuckle Stuart A
Arbuckle Stuart A is the EVP, COO at VERTEX PHARMACEUTICALS INC / MA. He oversees the company's operations and plays a key role in implementing the strategy. His expertise in the biopharmaceutical sector is essential for the development of the organization.
